Algorhythm Holdings Finalizes Prospectus for Up to 10M Share Resale by Streeterville Capital
Summary
Algorhythm Holdings filed a final prospectus for Streeterville Capital to resell up to 10 million shares, potentially diluting existing shareholders by 64.8% through a deeply discounted financing mechanism.
Key Events
-
Final Prospectus for Share Resale
Algorhythm Holdings filed a final prospectus registering up to 10,000,000 shares of common stock for resale by Streeterville Capital, LLC.
-
Significant Potential Dilution
The 10 million shares represent a potential 64.8% increase in outstanding shares, from 15,425,958 to 25,425,958, if all shares are issued and sold.
-
No Direct Proceeds to Company from Resale
The company will not receive any proceeds from Streeterville Capital's sale of these shares in the public market.
-
Deeply Discounted Issuance Terms
Shares are issued to Streeterville at 90% of the lowest daily volume-weighted average price (VWAP) over 10 trading days, with a floor of $0.10, indicating highly dilutive terms for existing shareholders.
Analysis
This final prospectus enables Streeterville Capital to resell up to 10 million shares of common stock, representing a potential 64.8% dilution for existing shareholders. While the company will not receive direct proceeds from these resales, these shares are issued to Streeterville at a significant discount to market price as repayment for prior pre-paid purchases. This continues a highly dilutive financing arrangement for a company already facing persistent going concern doubts and recent debt defaults.
At the time of this filing, RIME was trading at $0.71 on NASDAQ in the Technology sector, with a market capitalization of approximately $10.7M. The 52-week trading range was $0.54 to $4.58. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.